This small-cap company receives US FDA approval for a drug which has a market size of USD 3.55 billion!
Today, shares of the company saw a spurt in volume by more than 6 times on BSE.
On Tuesday, one of the Top Gainers on BSE, shares of Shilpa Medicare Ltd zoomed 15.59 per cent to Rs 269.55 per share from its previous closing of Rs 233.20.
The sudden increase in the stock price was that Shilpa Medicare received the U.S. Food and Drug Administration (US FDA) final approval for its ANDA for “Apremilast Tablets” for the treatment of adult patients with active psoriatic arthritis.
The product is executed from a contract manufacturing site. Apremilast Tablets, 10 mg, 20 mg and 30 mg are a generic equivalent of the reference listed drug (RLD) OTEZLA of Celgene. According to IQVIA MAT Q4 2022 data, the US market for Apremilast Tablets, 10 mg, 20 mg and 30 mg is approximately USD 3.55 billion.
Shilpa Medicare Ltd is an Indian pharmaceutical company that specializes in the development, manufacturing and marketing of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). The company has a global presence, with exports to over 65 countries.
According to the financials, Shilpa Medicare has a market cap of Rs 2,297 crore. The company reported positive numbers in its Quarterly Results and annual results.
Today, shares of the company saw a spurt in volume by more than 6 times on BSE.
Investors should keep an eye on this Small-Cap pharma stock.
Related articles
-
High ROE and high ROCE fertilisers & agrochemicals stock under Rs 75 gains over 10 per cent with a spurt in volume by more than 6 times on BSE; keep under the radar!
-
President of India’s portfolio gains Rs 377,41,33,581 and LIC’s portfolio gains Rs 88,03,28,542 from this multibagger penny stock at Rs 64 in just 1 day, scrip hit 52-week high!
-
750 per cent returns: Multibagger steel tubes and pipes manufacturers achieved highest ever sales volume in Q1FY25 of 1,22,155-MT; up 45 per cent YoY
-
Rs 34,800 crore order book: LIC-backed transport infrastructure developer stock jumps over 5 per cent with heavy volume; details inside!
-
Penny stock under Rs 10: This civil construction company bags a new order worth approx. Rs 23,00,00,000